Dr. Jennifer Roelands, MD is a double-boarded OB/GYN and Integrative Medicine physician with Functional Medicine training and a longevity focus. She specializes in perimenopause/menopause, hormone optimization (incl. men’s TRT), and personalized protocols, including medically supervised, compounded micro-dosed GLP-1s.
Dr. Roelands joins Heather Gray to demystify GLP-1 medications through a functional, patient-centered lens. They unpack what “microdosing” means with compounded formulations, how dose-flexibility can reduce common side effects, and why lifestyle foundations, resistance training, adequate protein, sleep, and metabolic hygiene, are non-negotiable for sustainable results. The conversation also explores off-label clinical observations around inflammation and “food noise,” considerations for women in peri/menopause, safety guardrails (who should not use GLP-1s), and how to vet a reputable compounding pharmacy. If you’ve wondered whether GLP-1s can fit into a long-term wellness plan without sacrificing muscle or metabolic health, this episode brings nuance, practicality, and hope.
- GLP-1 basics, clearly explained: Brand names vs. molecules (semaglutide, tirzepatide) and why newer “multi-agonists” are getting attention.
- Why microdosing matters: Compounded, personalized doses can ease nausea/constipation and match different metabolic profiles (e.g., 20–30 lb vs. 100+ lb goals).
- Lifestyle is the lever: Without protein, progressive strength training, and daily habits, weight typically rebounds when medication stops.
- Muscle preservation: In medically supervised programs that emphasize protein + lifting, losing muscle isn’t inevitable.
- Inflammation & “food noise”: Clinicians observe benefits beyond weight—less neuroinflammation and reduced intrusive food thoughts for some patients.
- Who should not use GLP-1s: History of medullary thyroid carcinoma, prior adverse reactions, or inappropriate use at very low body weights.
- Long-term unknowns: Decades of use exist, but research on very long-term effects is still evolving; indications are expanding (e.g., obesity, diabetes; others emerging).
- How to vet a compounder: Ask about third-party testing, sterility, adverse-event tracking, and quality control; local pharmacies can offer transparency and speed.
Find Dr. Jennifer Roelands:
